← The Wire
SRRKNasdaq
Scholar Rock Holding Corp
Biological Products, (No Diagnostic Substances) · DE · CIK 1727196
Develops novel antibodies targeting growth factors for rare neuromuscular diseases
$5.29B
Market cap
$54.96
Last close
+0.4%
1D
+11.7%
5D
2.1M
Volume
Price · last 39 sessions+18.2%
May 4L $43.80 · H $54.96Jun 29
180
Total filings
Jun 5, 2026
Last filing
12/31
Fiscal year end
424B5424B5Nov 14, 2025424B5424B5Oct 9, 2024424B5424B5Oct 7, 2024424B5424B5Oct 12, 2023424B5424B5Oct 11, 2023424B5424B5Jun 21, 2022424B5424B5Oct 30, 2020424B5424B5Oct 27, 2020424B5424B5Jun 21, 2019424B5424B5Jun 18, 2019
Insider Activity
In the 90 days to Feb 23, 2026: 9 sold $15.4M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 23, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sell | 7,427 | $46.94 | $349K |
| Feb 23, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sell | 857 | $47.86 | $41K |
| Feb 23, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sell | 200 | $48.48 | $10K |
| Feb 17, 2026 | Ho JunlinGENERAL COUNSEL | Sell | 9,580 | $46.53 | $446K |
| Feb 17, 2026 | Parlavecchio CarynCHRO | Sell | 9,035 | $46.53 | $420K |
| Feb 17, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sell | 7,989 | $46.53 | $372K |
| Feb 17, 2026 | Marantz Jing L.CHIEF MEDICAL OFFICER | Sell | 4,157 | $46.53 | $193K |
| Jan 22, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sell | 12,779 | $46.85 | $599K |
| Jan 22, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sell | 2,119 | $45.87 | $97K |
| Jan 16, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sell | 8,406 | $44.48 | $374K |
| Jan 16, 2026 | Ho JunlinGENERAL COUNSEL | Sell | 8,016 | $44.48 | $357K |
| Jan 16, 2026 | Parlavecchio CarynCHRO | Sell | 6,600 | $44.48 | $294K |
| Jan 16, 2026 | Marantz Jing L.CHIEF MEDICAL OFFICER | Sell | 5,798 | $44.48 | $258K |
| Jan 14, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sell | 13,112 | $45.20 | $593K |
| Jan 13, 2026 | Hallal DavidChief Executive Officer | Sell | 57,450 | $42.70 | $2.5M |
| Jan 13, 2026 | Vaishnaw AkshayPresident of R&D | Sell | 20,438 | $42.70 | $873K |
| Jan 13, 2026 | Sinha VikasChief Financial Officer | Sell | 16,755 | $42.70 | $715K |
| Jan 13, 2026 | Woods KeithChief Operating Officer | Sell | 16,746 | $42.70 | $715K |
| Dec 16, 2025 | Peng KatieDirector | Sell | 726 | $43.88 | $32K |
| Dec 16, 2025 | Peng KatieDirector | Sell | 280 | $44.63 | $12K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance